13 May 2016 - Deborah Wilkes
Archived
The US Food and Drug Administration (FDA) has announced a public meeting on the "potential development of a user-fee programme for OTC monograph drugs". The agency said it was "critically under-resourced" in this regulatory area.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.